Valuation: QuidelOrtho Corporation

Market Cap 728M 635M 600M 545M 1.02B 69.88B 1.02B 7.18B 2.77B 35.53B 2.74B 2.68B 114B P/E 2026 *
-2.58x
P/E 2027 * -3.83x
Enterprise Value 3.44B 3B 2.83B 2.57B 4.82B 330B 4.84B 33.94B 13.1B 168B 12.93B 12.64B 540B EV / Sales 2026 *
1.35x
EV / Sales 2027 * 1.29x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-4.24%
1 week-9.85%
Current month-26.40%
1 month-20.92%
3 months-22.31%
6 months-37.64%
Current year-62.82%
1 week 10.36
Extreme 10.36
11.97
1 month 10.36
Extreme 10.36
15.5
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
76.43
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
15/09/26 Exercice

Head of Human Resources

6,053 0.0088%
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
Change 5-day change 1-year change 3-year change Capi.($)
-4.24%-9.85%-64.29%-85.85% 728M
-0.40%+6.18%+20.11%-26.70% 17.65B
+0.57%+7.59%-44.18%+28.39% 1.89B
-0.90%-1.46%-32.67%+20.56% 870M
-0.27%+0.16%+49.84%-1.12% 779M
+1.13%+0.56%-36.46%-50.65% 642M
-0.97%-1.08%-43.47%-56.37% 555M
-4.10%+10.61%+54.40%+72.06% 436M
-2.23%-1.35%-44.36%-38.96% 439M
-1.09%+1.12%-10.13%-8.11% 395M
Average -1.25%+0.95%-15.12%-14.68% 2.44B
Weighted average by Cap. -0.54%+4.77%+7.71%-21.16%

Financials

2026 *2027 *
Net sales 2.54B 2.22B 2.1B 1.9B 3.56B 244B 3.58B 25.1B 9.68B 124B 9.56B 9.35B 399B 2.59B 2.26B 2.13B 1.94B 3.63B 249B 3.65B 25.56B 9.86B 126B 9.74B 9.52B 407B
Net income -282M -246M -232M -211M -394M -27.02B -396M -2.78B -1.07B -13.74B -1.06B -1.03B -44.2B -190M -166M -157M -142M -267M -18.26B -268M -1.88B -724M -9.28B -715M -699M -29.87B
Net Debt 2.71B 2.37B 2.23B 2.03B 3.8B 260B 3.82B 26.75B 10.32B 132B 10.19B 9.96B 426B 2.62B 2.29B 2.16B 1.96B 3.68B 252B 3.69B 25.88B 9.99B 128B 9.86B 9.64B 412B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
18/09/26 $10.62 -4.24% 2,978,699
17/09/26 $11.09 +2.97% 1,388,217
16/09/26 $10.77 +1.32% 1,667,660
15/09/26 $10.63 -4.41% 3,116,971
14/09/26 $11.12 -5.60% 2,812,402
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
10.62USD
Average target price
14.67USD
Spread / Average Target
+38.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!